Atorvastatin: Phase II started

ImmunoMod began a double-blind, placebo-controlled, U.S. Phase II trial of oral atorvastatin in 52 patients aged 5-19 with newly diagnosed Type I diabetes. Pfizer Inc. (PFE, New York, N.Y.), which is...